Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fennec Pharmaceuticals disclosed the grant of 15,000 incentive stock options to one new non-executive employee. The options carry an exercise price of $9.06, matching the June 18 closing price, and vest over three years.
Key figures
- Exercise price
- 9.06
- Shares granted
- 15000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.